DE68924661D1 - System zur Verabreichung von einem, eine Übung simulierenden Medikaments im geschlossenen Kreislauf. - Google Patents
System zur Verabreichung von einem, eine Übung simulierenden Medikaments im geschlossenen Kreislauf.Info
- Publication number
- DE68924661D1 DE68924661D1 DE68924661T DE68924661T DE68924661D1 DE 68924661 D1 DE68924661 D1 DE 68924661D1 DE 68924661 T DE68924661 T DE 68924661T DE 68924661 T DE68924661 T DE 68924661T DE 68924661 D1 DE68924661 D1 DE 68924661D1
- Authority
- DE
- Germany
- Prior art keywords
- exercise
- responses
- adaptive
- cad
- acute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 4
- 230000001154 acute effect Effects 0.000 abstract 3
- 230000008649 adaptation response Effects 0.000 abstract 3
- 230000004044 response Effects 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000003044 adaptive effect Effects 0.000 abstract 1
- 150000003943 catecholamines Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/044—Shape of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
- C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
- C07C215/60—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
- C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0448—Drug reservoir
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/13—Infusion monitoring
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15787588A | 1988-02-19 | 1988-02-19 | |
US07/308,683 US5108363A (en) | 1988-02-19 | 1989-02-09 | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68924661D1 true DE68924661D1 (de) | 1995-12-07 |
DE68924661T2 DE68924661T2 (de) | 1996-03-21 |
Family
ID=26854551
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68924661T Expired - Fee Related DE68924661T2 (de) | 1988-02-19 | 1989-02-17 | System zur Verabreichung von einem, eine Übung simulierenden Medikaments im geschlossenen Kreislauf. |
DE68928422T Expired - Fee Related DE68928422T2 (de) | 1988-02-19 | 1989-02-17 | Die Diagnose, die Bewertung und die Behandlung von einer Krankheit der Kranzarterie durch die Übungssimulierung unter Verwendung von einer geschlossenen Kreislauf Arzneimittellieferung eines übungssimulierenden Beta-Agonisten |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68928422T Expired - Fee Related DE68928422T2 (de) | 1988-02-19 | 1989-02-17 | Die Diagnose, die Bewertung und die Behandlung von einer Krankheit der Kranzarterie durch die Übungssimulierung unter Verwendung von einer geschlossenen Kreislauf Arzneimittellieferung eines übungssimulierenden Beta-Agonisten |
Country Status (13)
Country | Link |
---|---|
US (4) | US5108363A (de) |
EP (2) | EP0329464B1 (de) |
JP (2) | JP2806543B2 (de) |
AT (2) | ATE159710T1 (de) |
AU (1) | AU634152B2 (de) |
DE (2) | DE68924661T2 (de) |
DK (1) | DK73589A (de) |
ES (2) | ES2111973T3 (de) |
FI (1) | FI890776A (de) |
GR (2) | GR3018764T3 (de) |
IE (2) | IE80716B1 (de) |
NO (1) | NO890704L (de) |
NZ (1) | NZ239270A (de) |
Families Citing this family (125)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6144385A (ja) * | 1984-08-07 | 1986-03-04 | Tokyu Constr Co Ltd | 構造物内の放射線吸収体の探査方法 |
IL82997A0 (en) * | 1986-07-11 | 1987-12-20 | Tanabe Seiyaku Co | Method for epimerizing an optically active benzyl alcohol derivative |
US5108363A (en) * | 1988-02-19 | 1992-04-28 | Gensia Pharmaceuticals, Inc. | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
IE903614A1 (en) * | 1989-10-10 | 1991-04-24 | Glaxo Group Ltd | Phenethanolamine Compound |
US5023085A (en) * | 1989-11-29 | 1991-06-11 | Pfizer Inc. | Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
US5254087A (en) * | 1990-01-29 | 1993-10-19 | Ivra Systems, Inc. | Tourniquet apparatus for intravenous regional anesthesia |
US5556415A (en) * | 1990-01-29 | 1996-09-17 | Mcewen; James A. | Physiologic tourniquet for intravenous regional anesthesia |
US5607447A (en) * | 1993-09-28 | 1997-03-04 | Mcewen; James A. | Physiologic tourniquet |
US5281623A (en) * | 1990-08-27 | 1994-01-25 | Eli Lilly And Company | Method for treating inflammation |
AU3071992A (en) * | 1991-11-13 | 1993-06-15 | Gensia, Inc. | Methods for increasing the sensitivity and decreasing the side effects of pharmacological stress testing for coronary artery disease |
IL104365A0 (en) * | 1992-01-31 | 1993-05-13 | Gensia Pharma | Method and apparatus for closed loop drug delivery |
HUT64459A (en) * | 1992-03-31 | 1994-01-28 | Richter Gedeon Vegyeszet | Process and apparatus for the diagnostics of cardiovascular |
US5752521A (en) | 1993-11-12 | 1998-05-19 | Dardik; Irving I. | Therapeutic exercise program |
US5840026A (en) * | 1994-09-21 | 1998-11-24 | Medrad, Inc. | Patient specific dosing contrast delivery systems and methods |
US6397098B1 (en) * | 1994-09-21 | 2002-05-28 | Medrad, Inc. | Data communication and control for medical imaging systems |
US5551953A (en) * | 1994-10-31 | 1996-09-03 | Alza Corporation | Electrotransport system with remote telemetry link |
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US5775329A (en) * | 1995-06-07 | 1998-07-07 | Gensia, Inc. | Method and compounds for diagnosing coronary artery disease |
US5931853A (en) * | 1995-08-25 | 1999-08-03 | Mcewen; James A. | Physiologic tourniquet with safety circuit |
US5855589A (en) * | 1995-08-25 | 1999-01-05 | Mcewen; James A. | Physiologic tourniquet for intravenous regional anesthesia |
US6430997B1 (en) | 1995-11-06 | 2002-08-13 | Trazer Technologies, Inc. | System and method for tracking and assessing movement skills in multidimensional space |
PT873293E (pt) * | 1995-12-22 | 2001-11-30 | Abbott Lab | Processo melhorado para a preparacao de intermediarios de aldeido de alquilo ou arilo |
US5874601A (en) * | 1996-03-14 | 1999-02-23 | Abbott Laboratories | Process of protecting a 1,2-aminoalcohol for reductive amination coupling |
US5706822A (en) * | 1996-03-29 | 1998-01-13 | Kozz Incorporated | Method and computer program for creating individualized exercise protocols |
US5735814A (en) * | 1996-04-30 | 1998-04-07 | Medtronic, Inc. | Techniques of treating neurodegenerative disorders by brain infusion |
US5711316A (en) * | 1996-04-30 | 1998-01-27 | Medtronic, Inc. | Method of treating movement disorders by brain infusion |
US5713923A (en) * | 1996-05-13 | 1998-02-03 | Medtronic, Inc. | Techniques for treating epilepsy by brain stimulation and drug infusion |
AU4967997A (en) * | 1996-12-02 | 1998-06-29 | Chisso Corporation | Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same |
US6018679A (en) * | 1997-01-29 | 2000-01-25 | Novartis Finance Corp. | Iontophoretic transdermal delivery and control of adverse side-effects |
CN1311877C (zh) * | 1998-06-03 | 2007-04-25 | 斯科特实验室公司 | 为患者缓解与内科或外科处理相关的痛苦的设备和方法 |
CA2337129A1 (en) * | 1998-07-13 | 2000-01-20 | Genetronics, Inc. | Method and apparatus for electrically assisted topical delivery of agents for cosmetic applications |
US20020072489A1 (en) * | 1998-10-13 | 2002-06-13 | Whitehouse Martha J. | Angiogenically effective unit dose of FGF-2 and method of use |
US20030166550A1 (en) * | 1999-08-27 | 2003-09-04 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
US6440934B1 (en) | 1998-10-13 | 2002-08-27 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
AU6411199A (en) * | 1998-10-13 | 2000-05-01 | Chiron Corporation | Angiogenically effective unit dose of fgf and method of administering |
US6475514B1 (en) | 1998-12-03 | 2002-11-05 | Andrew Blitzer | Athletic patch |
US6361522B1 (en) * | 1999-10-21 | 2002-03-26 | Cardiac Pacemakers, Inc. | Drug delivery system for implantable cardiac device |
US9427520B2 (en) | 2005-02-11 | 2016-08-30 | Carefusion 303, Inc. | Management of pending medication orders |
US7860583B2 (en) | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
US11087873B2 (en) | 2000-05-18 | 2021-08-10 | Carefusion 303, Inc. | Context-aware healthcare notification system |
WO2001088828A2 (en) | 2000-05-18 | 2001-11-22 | Alaris Medical Systems, Inc. | Distributed remote asset and medication management drug delivery system |
US9069887B2 (en) * | 2000-05-18 | 2015-06-30 | Carefusion 303, Inc. | Patient-specific medication management system |
US10353856B2 (en) | 2011-03-17 | 2019-07-16 | Carefusion 303, Inc. | Scalable communication system |
US9741001B2 (en) | 2000-05-18 | 2017-08-22 | Carefusion 303, Inc. | Predictive medication safety |
US10062457B2 (en) | 2012-07-26 | 2018-08-28 | Carefusion 303, Inc. | Predictive notifications for adverse patient events |
AU2001271480B2 (en) | 2000-06-30 | 2007-02-15 | Lifewaves International, Inc. | Systems and methods for assessing and modifying an individual's physiological condition |
US7369890B2 (en) | 2000-11-02 | 2008-05-06 | Cardiac Pacemakers, Inc. | Technique for discriminating between coordinated and uncoordinated cardiac rhythms |
US6689117B2 (en) | 2000-12-18 | 2004-02-10 | Cardiac Pacemakers, Inc. | Drug delivery system for implantable medical device |
US7493162B2 (en) * | 2001-06-15 | 2009-02-17 | Cardiac Pacemakers, Inc. | Pulmonary vein stent for treating atrial fibrillation |
US7209783B2 (en) * | 2001-06-15 | 2007-04-24 | Cardiac Pacemakers, Inc. | Ablation stent for treating atrial fibrillation |
US7340303B2 (en) | 2001-09-25 | 2008-03-04 | Cardiac Pacemakers, Inc. | Evoked response sensing for ischemia detection |
MXPA04004246A (es) * | 2001-11-01 | 2004-09-10 | Scott Lab Inc | Interfaz de usuario para sistemas y metodos de suministro de sedacion y analgesia. |
US20030140928A1 (en) * | 2002-01-29 | 2003-07-31 | Tuan Bui | Medical treatment verification system and method |
US10173008B2 (en) | 2002-01-29 | 2019-01-08 | Baxter International Inc. | System and method for communicating with a dialysis machine through a network |
US8775196B2 (en) | 2002-01-29 | 2014-07-08 | Baxter International Inc. | System and method for notification and escalation of medical data |
US7236821B2 (en) * | 2002-02-19 | 2007-06-26 | Cardiac Pacemakers, Inc. | Chronically-implanted device for sensing and therapy |
CN1646142A (zh) * | 2002-04-18 | 2005-07-27 | Cv医药有限公司 | 包括给予A1腺苷激动剂以及β受体阻滞剂、钙通道阻滞剂、或强心苷的治疗心律失常的方法 |
US20040167804A1 (en) * | 2002-04-30 | 2004-08-26 | Simpson Thomas L.C. | Medical data communication notification and messaging system and method |
US20040176667A1 (en) * | 2002-04-30 | 2004-09-09 | Mihai Dan M. | Method and system for medical device connectivity |
US20040172300A1 (en) * | 2002-04-30 | 2004-09-02 | Mihai Dan M. | Method and system for integrating data flows |
US20050065817A1 (en) * | 2002-04-30 | 2005-03-24 | Mihai Dan M. | Separation of validated information and functions in a healthcare system |
US20040172301A1 (en) * | 2002-04-30 | 2004-09-02 | Mihai Dan M. | Remote multi-purpose user interface for a healthcare system |
US8234128B2 (en) | 2002-04-30 | 2012-07-31 | Baxter International, Inc. | System and method for verifying medical device operational parameters |
EP1517705B1 (de) * | 2002-06-20 | 2008-05-21 | The Governors Of The University Of Alberta | Dichloracetat in kombination mit kardioprotektiven oder hämodynamischen medikamenten |
US7089055B2 (en) * | 2002-06-28 | 2006-08-08 | Cardiac Pacemakers, Inc. | Method and apparatus for delivering pre-shock defibrillation therapy |
EP1556834A4 (de) | 2002-10-03 | 2009-04-01 | Scott Lab Inc | Systeme und verfahren zur bereitstellung von sensorfusion |
EP1554003A4 (de) * | 2002-10-03 | 2011-10-12 | Scott Lab Inc | Systeme und verfahren für trendanalysen in einem sedierungs- und analgesie-system |
US7072711B2 (en) | 2002-11-12 | 2006-07-04 | Cardiac Pacemakers, Inc. | Implantable device for delivering cardiac drug therapy |
US7627373B2 (en) | 2002-11-30 | 2009-12-01 | Cardiac Pacemakers, Inc. | Method and apparatus for cell and electrical therapy of living tissue |
US20050026884A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20050113318A1 (en) * | 2003-07-31 | 2005-05-26 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20090285900A1 (en) * | 2003-07-31 | 2009-11-19 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US7320675B2 (en) | 2003-08-21 | 2008-01-22 | Cardiac Pacemakers, Inc. | Method and apparatus for modulating cellular metabolism during post-ischemia or heart failure |
GB0403864D0 (en) * | 2004-02-20 | 2004-03-24 | Ucl Ventures | Modulator |
US7840263B2 (en) | 2004-02-27 | 2010-11-23 | Cardiac Pacemakers, Inc. | Method and apparatus for device controlled gene expression |
US7764995B2 (en) | 2004-06-07 | 2010-07-27 | Cardiac Pacemakers, Inc. | Method and apparatus to modulate cellular regeneration post myocardial infarct |
US7567841B2 (en) | 2004-08-20 | 2009-07-28 | Cardiac Pacemakers, Inc. | Method and apparatus for delivering combined electrical and drug therapies |
JP2008520287A (ja) | 2004-11-16 | 2008-06-19 | メドラッド インコーポレーテッド | 薬剤注入に対する患者搬送関数を決定し、患者反応をモデル化するシステム及び方法 |
EP2902053B1 (de) | 2004-11-24 | 2017-09-06 | Bayer Healthcare LLC | Vorrichtungen, Systeme und Verfahren zur Flüssigkeitsabgabe |
US8060219B2 (en) | 2004-12-20 | 2011-11-15 | Cardiac Pacemakers, Inc. | Epicardial patch including isolated extracellular matrix with pacing electrodes |
US7981065B2 (en) | 2004-12-20 | 2011-07-19 | Cardiac Pacemakers, Inc. | Lead electrode incorporating extracellular matrix |
US7616990B2 (en) | 2005-10-24 | 2009-11-10 | Cardiac Pacemakers, Inc. | Implantable and rechargeable neural stimulator |
US8182443B1 (en) * | 2006-01-17 | 2012-05-22 | Masimo Corporation | Drug administration controller |
JP2009531280A (ja) * | 2006-01-25 | 2009-09-03 | ウェルスタット セラピューティクス コーポレイション | 代謝障害を処置するための化合物 |
EP3376504A1 (de) | 2006-12-29 | 2018-09-19 | Bayer Healthcare, LLC | Patientenbasierte parametergenerierungssysteme für medizinische injektionsverfahren |
EP2117524B8 (de) * | 2007-01-29 | 2019-09-25 | National Research Council of Canada | Verwendung von catecholaminen und entsprechenden verbindungen als mittel gegen angiogenese |
EP2170165B1 (de) | 2007-07-17 | 2018-12-05 | Bayer Healthcare LLC | Systeme zur bestimmung von parametern für ein verfahren zur schätzung der kardiopulmonalen funktion und zur flüssigkeitsabgabe |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
US10089443B2 (en) | 2012-05-15 | 2018-10-02 | Baxter International Inc. | Home medical device systems and methods for therapy prescription and tracking, servicing and inventory |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
AU2009293019A1 (en) | 2008-09-19 | 2010-03-25 | Tandem Diabetes Care Inc. | Solute concentration measurement device and related methods |
US8554579B2 (en) | 2008-10-13 | 2013-10-08 | Fht, Inc. | Management, reporting and benchmarking of medication preparation |
US9421330B2 (en) * | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
AU2010278894B2 (en) | 2009-07-30 | 2014-01-30 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US20110137297A1 (en) * | 2009-09-17 | 2011-06-09 | Kiani Massi Joe E | Pharmacological management system |
JP6025718B2 (ja) | 2010-06-24 | 2016-11-16 | ベイヤー メディカル ケア インク. | 注入プロトコルのための医薬品の伝播およびパラメータ生成のモデル |
WO2013172811A1 (en) | 2012-05-14 | 2013-11-21 | Medrad, Inc. | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US8761717B1 (en) | 2012-08-07 | 2014-06-24 | Brian K. Buchheit | Safety feature to disable an electronic device when a wireless implantable medical device (IMD) is proximate |
CA2883273C (en) | 2012-08-31 | 2023-10-24 | Baxter Corporation Englewood | Medication requisition fulfillment system and method |
KR101695119B1 (ko) | 2012-10-26 | 2017-01-23 | 백스터 코포레이션 잉글우드 | 의료 투여분 조제 시스템을 위한 개선된 이미지 취득 |
NZ716476A (en) | 2012-10-26 | 2018-10-26 | Baxter Corp Englewood | Improved work station for medical dose preparation system |
US10430554B2 (en) | 2013-05-23 | 2019-10-01 | Carefusion 303, Inc. | Medication preparation queue |
US11182728B2 (en) | 2013-01-30 | 2021-11-23 | Carefusion 303, Inc. | Medication workflow management |
US9946844B2 (en) * | 2013-02-22 | 2018-04-17 | Cloud Dx, Inc. | Systems and methods for monitoring patient medication adherence |
EP2973366B1 (de) | 2013-03-13 | 2020-08-19 | Carefusion 303 Inc. | Patientenspezifisches medikamentenverwaltungssystem |
US9555379B2 (en) | 2013-03-13 | 2017-01-31 | Bayer Healthcare Llc | Fluid path set with turbulent mixing chamber, backflow compensator |
CN105074766A (zh) | 2013-03-13 | 2015-11-18 | 康尔福盛303公司 | 预测性用药安全 |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
JP2017525032A (ja) | 2014-06-30 | 2017-08-31 | バクスター・コーポレーション・イングルウッドBaxter Corporation Englewood | 管理された医療情報交換 |
US11107574B2 (en) | 2014-09-30 | 2021-08-31 | Baxter Corporation Englewood | Management of medication preparation with formulary management |
US11575673B2 (en) | 2014-09-30 | 2023-02-07 | Baxter Corporation Englewood | Central user management in a distributed healthcare information management system |
EP3937116A1 (de) | 2014-12-05 | 2022-01-12 | Baxter Corporation Englewood | Datenanalyse für dosiszubereitung |
JP2018507487A (ja) | 2015-03-03 | 2018-03-15 | バクスター・コーポレーション・イングルウッドBaxter Corporation Englewood | アラート統合を伴う薬局ワークフロー管理 |
CN116206744A (zh) | 2015-06-25 | 2023-06-02 | 甘布罗伦迪亚股份公司 | 具有分布式数据库的医疗装置系统和方法 |
US10898638B2 (en) | 2016-03-03 | 2021-01-26 | Bayer Healthcare Llc | System and method for improved fluid delivery in multi-fluid injector systems |
AU2017381172A1 (en) | 2016-12-21 | 2019-06-13 | Gambro Lundia Ab | Medical device system including information technology infrastructure having secure cluster domain supporting external domain |
CA3068544A1 (en) | 2017-08-31 | 2019-03-07 | Bayer Healthcare Llc | Method for dynamic pressure control in a fluid injector system |
CN110809482B (zh) | 2017-08-31 | 2023-03-07 | 拜耳医药保健有限公司 | 流体注入器系统体积补偿系统和方法 |
US11141535B2 (en) | 2017-08-31 | 2021-10-12 | Bayer Healthcare Llc | Fluid path impedance assessment for improving fluid delivery performance |
AU2018326380B2 (en) | 2017-08-31 | 2024-02-29 | Bayer Healthcare Llc | System and method for drive member position and fluid injector system mechanical calibration |
CA3067625A1 (en) | 2017-08-31 | 2019-03-07 | Bayer Healthcare Llc | Injector pressure calibration system and method |
US11654236B2 (en) | 2019-11-22 | 2023-05-23 | Tandem Diabetes Care, Inc. | Systems and methods for automated insulin delivery for diabetes therapy |
US11911595B2 (en) | 2020-05-18 | 2024-02-27 | Tandem Diabetes Care, Inc. | Systems and methods for automated insulin delivery response to meal announcements |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA570892A (en) * | 1959-02-17 | D. Moed Hendrik | Method of producing substituted aralkyl-, phenyl-, alkylamines | |
DE1144291B (de) * | 1957-11-05 | 1963-02-28 | Philips Nv | Verfahren zur Herstellung einer optisch-aktiven broncholytisch wirksamen Verbindung |
US3135797A (en) * | 1958-04-15 | 1964-06-02 | Colgate Palmolive Co | Aromatic amino antispasmodic compounds |
US3319623A (en) * | 1964-07-13 | 1967-05-16 | Seymour B London | Blood pressure monitors |
US3969410A (en) * | 1972-01-12 | 1976-07-13 | Boehringer Ingelheim Gmbh | 1-(2'-Alkyl-3',4'-dihydroxy-phenyl)-2-(phenylalkyl-amino)-alkanols-(1) and salts thereof |
US3803320A (en) * | 1968-07-24 | 1974-04-09 | Geigy Chem Corp | Control of insects,acarinae and nematodes with basically substituted 1-cyano-o-carbamoyl-formoximes |
US3803230A (en) * | 1969-05-30 | 1974-04-09 | Allen & Hanburys Ltd | 5-(2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide hydrochloride |
US3651806A (en) * | 1969-10-24 | 1972-03-28 | Philip I Hirshberg | Method and apparatus for administering digitalizing medications |
US4086272A (en) * | 1970-07-18 | 1978-04-25 | Pfizer Inc. | Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants |
GB1301134A (en) * | 1970-07-18 | 1972-12-29 | Pfizer Ltd | SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES |
NL7112938A (de) * | 1970-09-30 | 1972-04-05 | ||
US3987200A (en) * | 1972-04-12 | 1976-10-19 | Eli Lilly And Company | Method for increasing cardiac contractility |
JPS5310582B2 (de) * | 1973-04-28 | 1978-04-14 | ||
FR2328456A1 (fr) * | 1975-10-22 | 1977-05-20 | Bruneau & Cie Lab | Derives de phenylethanolamine, leur preparation et leur application en therapeutique |
US4080966A (en) * | 1976-08-12 | 1978-03-28 | Trustees Of The University Of Pennsylvania | Automated infusion apparatus for blood pressure control and method |
US4141359A (en) * | 1976-08-16 | 1979-02-27 | University Of Utah | Epidermal iontophoresis device |
US4078562A (en) * | 1976-08-16 | 1978-03-14 | Diana W. Friedman | Infusion pump with feedback control |
SE402569B (sv) * | 1976-11-09 | 1978-07-10 | Aga Ab | Anordning vid en andningsapparat for dykare |
DD144050A5 (de) * | 1978-06-05 | 1980-09-24 | Ciba Geigy Ag | Verfahren zur herstellung von n-alkylierten aminoalkoholen |
EP0006735B1 (de) * | 1978-06-28 | 1983-06-15 | Beecham Group Plc | Sekundäre Amine, ihre Herstellung, pharmazeutische Zusammensetzungen, die sie enthalten, und deren Verwendung |
DK269079A (da) * | 1978-07-03 | 1980-02-01 | Lilly Co Eli | Fremgangsmaade til fremstilling af phenethanolaminer |
US4845127A (en) * | 1978-07-03 | 1989-07-04 | Eli Lilly And Company | Phenethanolamines, compositions containing the same and method for effecting weight control |
DE3061205D1 (en) * | 1979-06-16 | 1983-01-05 | Beecham Group Plc | Secondary amines, their preparation and use in pharmaceutical compositions |
US4280494A (en) * | 1979-06-26 | 1981-07-28 | Cosgrove Robert J Jun | System for automatic feedback-controlled administration of drugs |
US4392849A (en) * | 1981-07-27 | 1983-07-12 | The Cleveland Clinic Foundation | Infusion pump controller |
DE3473439D1 (en) * | 1983-01-31 | 1988-09-22 | Lilly Co Eli | Improvements in or relating to phenethanolamines |
US4837305A (en) * | 1983-02-03 | 1989-06-06 | The Regents Of The University Of California | Derivatives of β-adrenergic antagonists |
US5135479A (en) * | 1983-08-18 | 1992-08-04 | Drug Delivery Systems, Inc. | Programmable control and mounting system for transdermal drug applicator |
EP0135905A3 (de) * | 1983-09-29 | 1986-10-22 | ASTA Pharma Aktiengesellschaft | Neue 1-(Alkyl-hydroxy-phenyl)-1-hydroxy-2-(alkylamino)-propane |
US4562206A (en) * | 1983-12-23 | 1985-12-31 | Key Pharmaceuticals, Inc. | Orally effective inotropic compounds |
US4865584A (en) * | 1984-02-08 | 1989-09-12 | Omni-Flow, Inc. | Cassette for programable multiple input infusion system |
CA1254091A (en) * | 1984-09-28 | 1989-05-16 | Vladimir Feingold | Implantable medication infusion system |
US5088981A (en) * | 1985-01-18 | 1992-02-18 | Howson David C | Safety enhanced device and method for effecting application of a therapeutic agent |
DE3586595T2 (de) * | 1985-06-10 | 1993-04-08 | Drug Delivery Systems Inc | Programmierbare kontrolle und bausystem eines verabreichungsgeraetes fuer transdermische arzneien. |
US4688577A (en) * | 1986-02-10 | 1987-08-25 | Bro William J | Apparatus for and method of monitoring and controlling body-function parameters during intracranial observation |
US4722726A (en) * | 1986-02-12 | 1988-02-02 | Key Pharmaceuticals, Inc. | Method and apparatus for iontophoretic drug delivery |
US4931046A (en) * | 1987-05-15 | 1990-06-05 | Newman Martin H | Iontophoresis drug delivery system |
WO1988008729A1 (en) * | 1987-05-15 | 1988-11-17 | Newman Martin H | Iontophoresis drug delivery system |
US5108363A (en) * | 1988-02-19 | 1992-04-28 | Gensia Pharmaceuticals, Inc. | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
US4846792A (en) * | 1988-03-08 | 1989-07-11 | Baxter International Inc. | Automatic infiltration detection system and method |
-
1989
- 1989-02-09 US US07/308,683 patent/US5108363A/en not_active Expired - Fee Related
- 1989-02-15 NZ NZ239270A patent/NZ239270A/xx unknown
- 1989-02-17 ES ES95101920T patent/ES2111973T3/es not_active Expired - Lifetime
- 1989-02-17 EP EP89301553A patent/EP0329464B1/de not_active Expired - Lifetime
- 1989-02-17 FI FI890776A patent/FI890776A/fi not_active Application Discontinuation
- 1989-02-17 DE DE68924661T patent/DE68924661T2/de not_active Expired - Fee Related
- 1989-02-17 AT AT95101920T patent/ATE159710T1/de not_active IP Right Cessation
- 1989-02-17 ES ES89301553T patent/ES2081299T3/es not_active Expired - Lifetime
- 1989-02-17 IE IE960742A patent/IE80716B1/en not_active IP Right Cessation
- 1989-02-17 DE DE68928422T patent/DE68928422T2/de not_active Expired - Fee Related
- 1989-02-17 IE IE52689A patent/IE71651B1/en not_active IP Right Cessation
- 1989-02-17 AU AU30088/89A patent/AU634152B2/en not_active Ceased
- 1989-02-17 EP EP95101920A patent/EP0658538B1/de not_active Expired - Lifetime
- 1989-02-17 AT AT89301553T patent/ATE129644T1/de not_active IP Right Cessation
- 1989-02-17 DK DK073589A patent/DK73589A/da not_active Application Discontinuation
- 1989-02-20 NO NO89890704A patent/NO890704L/no unknown
- 1989-02-20 JP JP1042887A patent/JP2806543B2/ja not_active Expired - Lifetime
-
1990
- 1990-12-11 US US07/625,362 patent/US5286252A/en not_active Expired - Fee Related
-
1993
- 1993-12-07 US US08/163,839 patent/US5460605A/en not_active Expired - Fee Related
- 1993-12-15 US US08/169,536 patent/US5395970A/en not_active Expired - Fee Related
-
1996
- 1996-01-24 GR GR960400162T patent/GR3018764T3/el unknown
-
1998
- 1998-01-14 GR GR980400065T patent/GR3025892T3/el unknown
- 1998-02-19 JP JP10037422A patent/JPH10276991A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH10276991A (ja) | 1998-10-20 |
GR3018764T3 (en) | 1996-04-30 |
AU634152B2 (en) | 1993-02-18 |
GR3025892T3 (en) | 1998-04-30 |
IE890526L (en) | 1989-08-19 |
NO890704D0 (no) | 1989-02-20 |
ES2111973T3 (es) | 1998-03-16 |
DK73589D0 (da) | 1989-02-17 |
IE960742L (en) | 1989-08-19 |
ES2081299T3 (es) | 1996-03-01 |
US5286252A (en) | 1994-02-15 |
EP0329464A3 (de) | 1991-07-17 |
EP0329464B1 (de) | 1995-11-02 |
US5108363A (en) | 1992-04-28 |
DE68928422D1 (de) | 1997-12-04 |
FI890776A0 (fi) | 1989-02-17 |
US5395970A (en) | 1995-03-07 |
IE80716B1 (en) | 1998-12-30 |
AU3008889A (en) | 1989-08-24 |
EP0658538B1 (de) | 1997-10-29 |
ATE159710T1 (de) | 1997-11-15 |
DE68928422T2 (de) | 1998-02-26 |
DK73589A (da) | 1989-08-20 |
IE71651B1 (en) | 1997-02-26 |
US5460605A (en) | 1995-10-24 |
EP0329464A2 (de) | 1989-08-23 |
ATE129644T1 (de) | 1995-11-15 |
JP2806543B2 (ja) | 1998-09-30 |
NO890704L (no) | 1989-08-21 |
NZ239270A (en) | 1993-10-26 |
DE68924661T2 (de) | 1996-03-21 |
EP0658538A1 (de) | 1995-06-21 |
FI890776A (fi) | 1989-08-20 |
JPH0217048A (ja) | 1990-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68924661D1 (de) | System zur Verabreichung von einem, eine Übung simulierenden Medikaments im geschlossenen Kreislauf. | |
Grandin | Thinking in pictures, expanded edition: My life with autism | |
Gardner et al. | Environmental enrichment and deprivation: effects on learning, memory and exploration | |
Faaborg-Andersen et al. | Action potentials from internal laryngeal muscles during phonation | |
Mills | Pain behaviors in infants and toddlers | |
Carlisle et al. | The X-organ of Crustacea | |
Bohdanecka et al. | Amnesic effects of small bilateral brain puncture in the mouse | |
Nash | The effects of warm-up activities on small group divergent problem-solving with young children | |
Clark et al. | A form of congenital myotonia in goats | |
JPS51118841A (en) | A drug for improving and treating clouding of consciousness | |
Kellogg et al. | " Ambiguous conditioning," a phenomenon of bilateral transfer. | |
Groden et al. | Understanding challenging behavior: A step-by-step behavior analysis guide. | |
Lynch et al. | Within-session data. | |
Collins | Therapist behavior in behavior therapy: Comments on Thompson and Williams (1985) and Wolpe (1985). | |
Jarus et al. | The effect of kinesthetic stimulation on acquisition and retention of a gross motor skill | |
Bean-Bayog et al. | Special report: AMSAODD: Plan for certification of members, 1985–1986. | |
Conyne et al. | A HIM-G interaction process analysis study of facilitator-and self-directed groups | |
Sanz Ruiz et al. | Interactive effect of self-efficacy and incentive value on peripheral physiological reactivity in the performance of a cognitive task. | |
Berg | Chromium picolinate--Still hot on the market | |
Repo | The holistic approach to rehabilitation: a commentary | |
Joseph | Animal illness and human emotion. Neurologic problems | |
Imboden et al. | Practical psychiatry in medicine: II. Behavior: An overview. | |
Paulson | Techniques and procedures used to study the metabolism of pesticides in large animals | |
Swinson | Appraisal: A re-evaluation. | |
Mehta et al. | Assessing the efficacy of home practice relaxation procedure. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |